GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.02
arrow_downward
-0.98%(-0.030) 1D
$3.02
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.11
High
$3.21
Low
$2.93
Mkt. cap
304.57M
Avg. vol.
203.02K
Volume
231.99K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.11
High
$3.21
Low
$2.93
Mkt. cap
304.57M
Avg. vol.
203.02K
Volume
231.99K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
GuruFocus
·
8 hours ago
Galectin Therapeutics (GALT) Posts Q3 Earnings Beat with Narrower Loss
AlphaStreet
·
9 hours ago
Galectin Therapeutics Releases Q3 2026 Financial Results
marketscreener.com
·
13 hours ago
Galectin Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
scanx.trade
·
14 hours ago
Galectin Therapeutics Q3 Results: Loss narrows 69% YoY to $0.04 per share
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com